Skin treatments developer Dermira is adding another experimental drug to its pipeline that it plans to test as a potential treatment for eczema, through a deal announced this morning with healthcare giant Roche. But in picking up the global rights to lebrikizumab, Menlo Park, CA-based Dermira (NASDAQ: DERM) is entering a suddenly crowded field of […]
NYS Entity Status
NYS Filing Date
FEBRUARY 01, 2013
NYS DOS ID#
220 FRONT STREET
NEW YORK, NEW YORK, 10038
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2013 - BASIL DERMATOLOGY, P.C.
AROUND THE WEB
- Dermira Commits $135M for Global Rights to Roche Eczema Drug
By Frank Vinluan - Tuesday Aug 8, 2017
- New York Today: New York Today: New Subway Clocks
By JONATHAN WOLFE - Monday Aug 7, 2017
Monday: Rolling out new subway clocks, the Corkscrew Theater Festival, and National Lighthouse Day.
- Conviction Overturned for ex-NY Assembly Speaker Sheldon Silver
Thursday Jul 13, 2017
A federal appeals court has overturned the corruption conviction of former New York Assembly Speaker Sheldon Silver.
- Woody Allen’s ‘Wonder Wheel’ set to close NY Film Festival
By Deadline - Tuesday Jul 25, 2017
The film will go into limited release December 1.
- When Will A.I. Replace Doctors?
By Jeff Engel - Monday Jun 26, 2017
This story is part of an ongoing series on A.I. in healthcare. A companion piece today looks at advances from GE, IBM, and other competitors. Even as big companies race to build up their artificial intelligence capabilities, the prospect of using A.I. technologies in healthcare raises more questions than answers. Here are four key issues voiced by […]
- Neighborhoods That Play Hard to Get
By STEFANOS CHEN - Friday Aug 11, 2017
In some New York neighborhoods, the housing stock is great, but turnover is so low, word of mouth is the best search engine.